Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
K. Bayfield (Sydney, Australia), O. Weinheimer (Heidelberg, Germany), C. Boyton (Sydney, Australia), R. Fitzpatrick (Sydney, Australia), A. Middleton (Sydney, Australia), B. Kennedy (Sydney, Australia), A. Blaxland (Sydney, Australia), G. Jayasuriya (Sydney, Australia), N. Caplain (Sydney, Australia), M. Wielpuetz (Heidelberg, Germany), L. Yu (Minneosota, United States of America), C. Galban (Michigan, United States of America), T. Robinson (Stanford, United States of America), B. Bartholmai (Minneosota, United States of America), P. Gustafsson (Skövde, Sweden), D. Fitzgerald (Sydney, Australia), H. Selvadurai (Sydney, Australia), P. Robinson (Sydney, Australia). Late Breaking Abstract - Use of ultra-low dose CT does not impact structure-function relationships in early Cystic Fibrosis lung disease. 4310

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Short-term effects of a novel bronchial drainage device in Cystic Fibrosis patients Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017 A new gold standard for assessing CT in early CF lung disease? Source: International Congress 2014 – Cystic fibrosis: assessment and treatment Year: 2014 Late Breaking Abstract - Longitudinal progression of emphysema-like lung on CT in a general population study Source: International Congress 2019 – Comorbidities galore in respiratory patients Year: 2019 Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI) Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020 Multidisciplinary board for interstitial lung disease: Relevance for real life? Source: International Congress 2015 – New insights into IIPs Year: 2015 Late Breaking Abstract - Lessons from introducing DEKAs as a means of vitamin supplementation in paediatric Cystic Fibrosis patients. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 LATE-BREAKING ABSTRACT: Early following up of gas trapping with computed tomography during normal breathing in infant with Cystic Fibrosis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Late Breaking Abstract - Transbronchial lung cryobiopsy for interstitial lung disease diagnosis: results of the COLDICE Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Late Breaking Abstract - Use of mepolizumab in bronchiectasis with underlying eosinophilic condition Source: International Congress 2018 – New methods for diagnosing and treating lung diseases Year: 2018 Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 What is a NICE definition of lung disease in patients with Cystic Fibrosis and its impact on treatment? Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018